ProCE Banner Activity

Exciting Times for Inhibiting Depression

Clinical Thought

Modulators of glutamate and GABA recently have emerged as new options for difficult-to-treat depression. Read this expert commentary to learn more about their use in clinical practice and future research directions.

Released: May 31, 2023

Share

Faculty

Charles DeBattista

Charles DeBattista, DMH, MD

Chief, Depression Research Clinic
Director, Medical Student Education in Psychiatry
Professor of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
Stanford, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Sage Therapeutics, Inc. and Biogen.

Sage Therapeutics, Inc. and Biogen

Disclosure

Primary Author

Charles DeBattista, DMH, MD

Chief, Depression Research Clinic
Director, Medical Student Education in Psychiatry
Professor of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
Stanford, California

Charles DeBattista, DMH, MD: researcher: Compass, Janssen, Relmada, Sage.